Safety and Tolerability of BI 685509 in Healthy Subjects

NCT03116906 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: BI 685509
DRUG: Placebo

Sponsor

Boehringer Ingelheim